PDCA循环在癌痛患者第三阶梯镇痛药物使用管理中的应用  

Application of PDCA cycle in the management of the third-step analgesics use in cancer pain patients

作　　者：金慧[1] 蒋正立[1] 夏爱晓[1] 周鹏[1] 朱燕舞[1] 饶跃峰 JIN Hui;JIANG Zhengli;XIA Aixiao;ZHOU Peng;ZHU Yanwu;RAO Yuefeng(Department of pharmacy Taizhou Hospital of Zhejiang Province,Linhai 317000,China;Department of Pharmacy,the First Affiliated Hospital of Zhejiang University,Hangzhou 310003,China)

机构地区：[1]浙江省台州医院药剂科,临海317000 [2]浙江大学附属第一医院药学部,杭州310003

出　　处：《中国临床药学杂志》2020年第2期121-125,共5页Chinese Journal of Clinical Pharmacy

基　　金：浙江省医药卫生科技计划面上项目(编号2020KY1036)。

摘　　要：目的探讨PDCA(计划-执行-检查-处理)循环在住院癌痛患者第三阶梯镇痛药物使用管理中的作用。方法运用PDCA循环对第三阶梯镇痛药物在住院癌痛患者中的使用进行干预,比较干预前与干预后第1周期、第2周期住院患者第三阶梯镇痛药物的使用不合理情况。结果经过2个周期的干预,住院癌痛患者第三阶梯镇痛药物的使用不合理率从15.83%降低到5.84%,其中非癌痛规范化治疗(GPM)示范病房的不合理率从42.86%降低到15.46%,不合理用药类型中用药有禁忌证的比例从5.41%降低到0.39%,爆发痛处理不规范的比例从4.63%降低到1.56%,差异均具有统计学意义。结论 PDCA循环有效降低了住院癌痛患者第三阶梯镇痛药物的使用不合理率,可在癌痛治疗药物管理中推广。AIM To investigate the effect of PDCA(plan-do-check-act)cycle in the management of the third-step analgesics for cancer pain inpatients.METHODS PDCA cycle was applied to intervene the use of third-step analgesics in cancer pain inpatients,and the irrational use of the third-step analgesics in cancer pain inpatients before and after the first and the second PDCA cycles was compared.RESULTS After two cycles of intervention,the irrational use rate of the third-step analgesics for cancer pain inpatients decreased from15.83%to 5.84%.The irrational use rate of non-GPM(good pain management)wards decreased from 42.86%to 15.46%.Among the types of irrational use,the irrational use rate of contraindications decreased from 5.41%to 0.39%,and the irrational use rate of breakthrough pain treatment decreased from 4.63%to 1.56%.All the data were statistically significant.CONCLUSION PDCA cycle can effectively reduce the irrational use rate of the third-step analgesics for cancer pain inpatients,and can be popularized in the management of cancer pain drugs.

关 键 词：PDCA循环 癌痛 第三阶梯镇痛药物 

分 类 号：R969.3[医药卫生—药理学]